Trading volume for Labstyle Innovat Cm was 37K on Tuesday. Overall, volume was down 91.09% under the stocks normal daily volume.
Traders are a little more bearish on shares of Labstyle Innovat Cm if you look at the change in short interest. The firm saw a rise in short interest between September 29, 2017 and October 13, 2017 of 4.94%. Short shares increased from 134,096 to 140,717 over that period. Days to cover increased 4.0 to 10.0 and the short interest percentage is 0.01% as of October 13.
A few notable investment firms have updated their holdings. Advisor Group, Inc. added to its investment by buying 3,500 shares an increase of 581.4% from 06/30/2017 to 09/30/2017. Advisor Group, Inc. currently owns 4,102 shares worth $8,000. The total value of its holdings increased 700.0%.
On August 29 analysts at Aegis updated guidance on DRIO with an initial rating of “Buy”.
The company is trading unchanged since yesterday’s close of 1.62. The most current P/E ratio is N/A and the market value is 16.59M. As of the latest earnings report the EPS was $-1.24 with 10.35M shares presently outstanding.
DarioHealth Corp, formerly Labstyle Innovations Corp, launched on August 11, 2011, is a digital health (mHealth) company. The Company is involved in developing and commercializing a technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The Business’s product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with a pocket-sized, blood glucose monitoring device, Dario Smart Meter..